This article was originally published in The Gray Sheet
Agency's Center for Devices and Radiological Health issues "Guidance Document for Vascular Prostheses 510(k) Submissions," developed "as a special control to support reclassification from Class III to Class II for vascular graft prostheses," Nov. 26. The center simultaneously issues "Guidance for Annuloplasty Rings 510(k) Submissions," also as a special control, and "Guidance for Cardiovascular Intravascular Filter 510(k) Submissions," which supersedes the agency's Feb. 11, 1997 guidance on premarket notification for the same devices. Draft "Guidance for Resorbable Adhesion Barrier Devices for Use in Abdominal and/or Pelvic Surgery" is also available for comment on CDRH web site
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.